Natco Pharma's net profit increased by 4.9% to ₹406 crore in Q4.
The company recorded its highest-ever consolidated revenue and profits in the full year FY25, with total revenue at ₹4,784 crore, reflecting 16% growth.
Natco Pharma had a net profit of ₹1,883 crore for the year on a consolidated basis, marking a 36% growth from the previous year.
Despite a strong year, the company anticipates a possible 20% dip in revenue and 30% drop in profits for the financial year 2025-26 due to geopolitical uncertainties and pricing pressure in the US market.